KM Research Hub
← 返回论文库
已完成 入排:排除 图源:可得 入排置信度 0.98

Differential Effect of Ticagrelor Versus Clopidogrel by Causative Classification of Stroke Classification and Vascular Cellular Adhesion Molecule-1 Level on the Risk of Recurrent Stroke: A Post Hoc Analysis of the CHANCE-2 Trial.

Hui Li, Xue Xia, Qin Xu, Xia Meng, Yongjun Wang, Anxin Wang

J Am Heart Assoc 15(1) e042259

PMID41413755
PMCIDPMC12909013
DOI10.1161/JAHA.125.042259
发表日期2025-12-18
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: VCAM-1 (vascular cellular adhesion molecule-1) is an inflammatory biomarker linked to the occurrence and recurrence of stroke. However, it is uncertain if dual antiplatelet treatments may have distinct benefit for patients with varied stroke causes and VCAM-1 levels. METHODS: This post hoc study of the CHANCE-2 (Ticagrelor or Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events II) trial included 5651 patients in total. All patients were classified using the Causative Classification of Stroke system categorization as well as the mean of baseline VCAM-1 level. The primary outcome was any stroke within 90 days. During the 90-day follow-up period, the cumulative incidence of outcomes between 2 dual antiplatelet treatments was compared using the Kaplan-Meier analysis and log-rank test. The Cox proportional hazards model was used to further assess the hazard ratios (HRs) and 95% CIs for the associations of small artery occlusion cause and VCAM-1 level with efficiency and safety outcomes. RESULTS: The median age of 5651 patients was 64.8 years, 1908 of whom were women. Among all the subtypes, patients with nonelevated VCAM-1 (<1715.9 ng/mL) and small artery occlusion subtype (N=1252) got more benefit from aspirin-ticagrelor therapy to reduce recurrent stroke within 90 days (7.5% versus 2.9%, hazard ratio [HR], 0.37 [95% CI, 0.22-0.64], P<0.001). Regarding safety outcomes, the risk of mild bleeding was increased in the ticagrelor-aspirin group (1.4% versus 6.7%, HR, 4.85 [95% CI, 2.36-9.96]), but no significant difference was found between the 2 groups in moderate or severe bleeding (0.6% versus 0.5%, HR, 0.75 [95% CI, 0.17-3.35]). CONCLUSIONS: VCAM-1 level combined with ischemic stroke cause classification subtypes might predict the effect of ticagrelor-aspirin or clopidogrel-aspirin dual antiplatelet therapy in preventing recurrent stroke within 90 days in patients with minor ischemic stroke or transient ischemic attack carrying CYP2C19 loss-of-function alleles. Patients with small artery occlusion subtype and nonelevated VCAM-1 received more clinical benefit from ticagrelor-aspirin versus clopidogrel-aspirin. REGISTRATION: URL: http://www.clinicaltrials.gov; Unique Identifier: NCT04078737.

KM 提取结果

1 个 Figure · 4 个 KM 面板

进入结果中心
KM Figure4 个面板

Figure 2

Figure 2. Cumulative incidence of stroke recurrence according to VCAM‐1 levels and SAO cause of CCS system. A , Cumulative incidence of stroke recurrence in group SAO with nonelevated VCAM‐1. B , Cumulative incidence of stroke recurrence in group SAO with elevated VCAM‐1. C , Cumulative incidence of stroke recurrence in group non‐SAO with nonelevated VCAM‐1. D , Cumulative incidence of stroke recurrence in group non‐SAO with elevated VCAM‐1. CCS indicates Causative Classification of Stroke; SAO, small artery occlusion; and VCAM‐1, vascular cell adhesion molecule 1.

A

Cumulative incidence of stroke recurrence

Figure 2 · Panel A

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel A 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 2 条,实际恢复 1 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
B

Cumulative incidence of stroke recurrence

Figure 2 · Panel B

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel B 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 1:off origin start曲线 2:frequent upward jumps曲线 2:off origin start
查看结果
C

Cumulative incidence of stroke recurrence

Figure 2 · Panel C

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel C 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 2 条,实际恢复 1 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
D

Cumulative incidence of stroke recurrence

Figure 2 · Panel D

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel D 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线缺失:预期 2 条,实际恢复 1 条曲线 1:off origin start曲线 2:short span曲线 2:frequent upward jumps
查看结果
其他 Figure(1,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1Figure 1. Diagram showing the flow of patients through the current study. CSS indicates Causative Classification of Stroke; NIHSS, National Institutes of Health Stroke Scale; SAO, small artery occlusion; TIA, transient ischemic attack; and VCAM‐1, vascular cell adhesion molecule 1.
非 KM Figure